Streamlining Medi-Cal Specialty Drug Prior Auth Workflows

The Challenge of Medi-Cal Specialty Drug Prior Auth

Specialty drugs, including biologics and complex injectables, are critical for many Medi-Cal patients but frequently require prior authorization. The process is often manual, demanding significant staff time to determine benefit coverage (medical vs. pharmacy), gather extensive clinical documentation, and submit via disparate payer channels. This complexity contributes to administrative burden and can delay patient access to vital medications.

Common Friction Points in Medi-Cal Specialty Drug PA

• **Benefit-Side Misclassification:** Incorrectly identifying whether a specialty drug falls under the medical or pharmacy benefit for a specific Medi-Cal plan.
• **Disparate Submission Channels:** Navigating multiple Medi-Cal provider portals, X12 278 EDI, or ePA platforms for different drug types.
• **Step-Therapy Documentation Gaps:** Failing to adequately document prior-line therapies required for biologic approvals.
• **Site-of-Care Policy Mismatches:** Submitting for infusion at a site (e.g., hospital outpatient) that conflicts with Medi-Cal's site-of-care policies.
• **Specialty Pharmacy Handoff Delays:** Inefficient coordination between PA approval and specialty pharmacy fulfillment for patient-administered drugs.

Klivira's Automated Approach for Medi-Cal Specialty Drug PA

Klivira's platform addresses the specific challenges of Medi-Cal specialty drug prior auth by automating key workflow components. We leverage intelligent policy engines and robust integration capabilities to ensure accurate submissions, reduce manual effort, and accelerate time-to-medication for California Medicaid patients. Our solution spans both medical and pharmacy benefits, providing a unified approach.

Key Automation Features for Medi-Cal Specialty Drugs

• **Automated Benefit-Side Determination:** Klivira's policy engine accurately identifies if a specialty drug for a Medi-Cal patient falls under the medical or pharmacy benefit.
• **Multi-Channel Submission:** Routing pharmacy-benefit specialty drugs via NCPDP SCRIPT ePA partners (e.g., CoverMyMeds, Surescripts) and medical-benefit drugs via X12 278, payer portals, or Da Vinci PAS where supported by Medi-Cal.
• **Clinical Documentation & Step-Therapy Automation:** Extracting medication history and treatment response data from EMRs (FHIR MedicationRequest, Observation resources) to fulfill Medi-Cal's step-therapy requirements.
• **Site-of-Care Policy Alignment:** Incorporating site-of-care logic into submissions, flagging potential mismatches with Medi-Cal policies before submission.
• **Specialty Pharmacy Fulfillment Coordination:** Streamlining the post-approval handoff to specialty pharmacies for patient-administered drugs, minimizing delays.

Leveraging Standards for Medi-Cal Prior Authorization

Klivira is built upon industry-leading standards to ensure interoperability and efficiency for Medi-Cal prior authorizations. We utilize NCPDP SCRIPT for pharmacy ePA, FHIR resources for clinical data exchange, and support X12 278 for medical benefit submissions. Where available, our platform can also interface with Da Vinci PAS conformant endpoints, aligning with evolving industry best practices for electronic prior authorization.

Integrating with Your EMR for Seamless Workflows

Our platform integrates directly with your existing EMR system, pulling necessary patient demographics, clinical notes, and medication histories directly from FHIR-enabled endpoints. This deep integration reduces manual data entry, improves data accuracy, and ensures that all required information for Medi-Cal specialty drug prior auth is consistently captured and submitted, minimizing the risk of rejections due to incomplete documentation.